For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Novozymes A/S (NVZMY) is a stock that can certainly grab ...
Novozymes and Chr. Hansen have announced that the name of the future combined company will be 'Novonesis'. Novonesis means 'A new beginning' and derives from the Greek word 'genesis'. The name ...
COPENHAGEN, Oct 7 (Reuters) - When Denmark's Novozymes first wondered in 2000 how its mass-produced enzymes could be used to make advanced biofuel, the industry did not exist and only now is the fruit ...
FILE PHOTO: Containers are seen in a laboratory in an enzyme factory of Danish biopharmaceutical company Novozymes in Beijing, China May 24, 2011. REUTERS/David Gray/File Photo COPENHAGEN (Reuters) - ...
Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash ...
As a result of its actions to reduce carbon emissions and mitigate the business risks of climate change, Novozymes has been awarded with a position on the A List: The CDP Climate Performance ...
The merger, announced in a joint statement Monday, will see the dissolution of Chr. Hansen and is expected to complete in the fourth quarter of 2023. The new group will have annual revenues of ...
Novozymes, a global producer of enzymes that controls roughly 48% of the market, is seeing its focus on food and beverage solutions and innovation pay off in 2018. Globally, enzyme technology has been ...
The economic power of the microbial world never ceases to amaze me. As I spent most of my career as a natural products pharmacologist, readers here are quite familiar with the microbial world as a ...
Novozymes, a supplier of industrial enzymes and microorganisms, is expanding its base of operations to become a manufacturer of biopharmaceutical ingredients. “We have been involved in the microbial ...
Novozymes is increasing its investment into alternative proteins, specifically its portfolio of enzyme solutions that can be used for the production of alternative protein food and beverage products, ...
COPENHAGEN (Reuters) - Novozymes , the world's top industrial enzymes maker, is buying U.S. based EMD/Merck Crop BioScience for $275 million from Merck KGaA , boosting its presence in the fast-growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results